Caseware UK (AP4) 2022.0.179 2022.0.179 2022-12-312022-12-3172022-01-01falseNo description of principal activity6truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09382373 2022-01-01 2022-12-31 09382373 2021-01-01 2021-12-31 09382373 2022-12-31 09382373 2021-12-31 09382373 c:Director2 2022-01-01 2022-12-31 09382373 d:OfficeEquipment 2022-01-01 2022-12-31 09382373 d:OfficeEquipment 2022-12-31 09382373 d:OfficeEquipment 2021-12-31 09382373 d:CurrentFinancialInstruments 2022-12-31 09382373 d:CurrentFinancialInstruments 2021-12-31 09382373 d:Non-currentFinancialInstruments 2022-12-31 09382373 d:Non-currentFinancialInstruments 2021-12-31 09382373 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 09382373 d:CurrentFinancialInstruments d:WithinOneYear 2021-12-31 09382373 d:Non-currentFinancialInstruments d:AfterOneYear 2022-12-31 09382373 d:Non-currentFinancialInstruments d:AfterOneYear 2021-12-31 09382373 d:ShareCapital 2022-12-31 09382373 d:ShareCapital 2021-12-31 09382373 d:SharePremium 2022-12-31 09382373 d:SharePremium 2021-12-31 09382373 d:RetainedEarningsAccumulatedLosses 2022-12-31 09382373 d:RetainedEarningsAccumulatedLosses 2021-12-31 09382373 c:OrdinaryShareClass1 2022-01-01 2022-12-31 09382373 c:OrdinaryShareClass1 2022-12-31 09382373 c:OrdinaryShareClass1 2021-12-31 09382373 c:FRS102 2022-01-01 2022-12-31 09382373 c:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 09382373 c:FullAccounts 2022-01-01 2022-12-31 09382373 c:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 09382373 d:Subsidiary1 2022-01-01 2022-12-31 09382373 d:Subsidiary1 1 2022-01-01 2022-12-31 09382373 4 2022-01-01 2022-12-31 09382373 6 2022-01-01 2022-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 09382373









CRESCENT OPS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2022

 
CRESCENT OPS LIMITED
REGISTERED NUMBER: 09382373

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2022

2022
2021
Note
£
£

Fixed assets
  

Investments
 5 
930
930

  
930
930

Current assets
  

Debtors
  
526,729
526,321

Cash at bank and in hand
 6 
1,063
95,123

  
527,792
621,444

Creditors: amounts falling due within one year
 7 
(103,750)
(795,776)

Net current assets/(liabilities)
  
 
 
424,042
 
 
(174,332)

Total assets less current liabilities
  
424,972
(173,402)

Creditors: amounts falling due after more than one year
  
(853,743)
-

  

Net liabilities
  
(428,771)
(173,402)


Capital and reserves
  

Called up share capital 
 9 
33,311
33,311

Share premium account
  
2,745,096
2,745,096

Profit and loss account
  
(3,207,178)
(2,951,809)

  
(428,771)
(173,402)


Page 1

 
CRESCENT OPS LIMITED
REGISTERED NUMBER: 09382373
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2022

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 


B Clare
Director

Date: 2 October 2023

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
CRESCENT OPS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

1.


General information

Crescent OPS Limited is a private company limited by shares and incorporated in England. The registered office is 101 New Cavendish Street, 1st Floor South, London, United Kingdom, W1W 6XH.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

In assessing the ability of the company to operate as a going concern, management have evaluated current and forecasted operational results, and the solvency of the company. Given that the company is in a net deficit position the directors have obtained assurances from its beneficial owners to continue to provide adequate funds to meets its obligations, and not to demand repayment of any funds due to them, until the company is in a financial position to do so. As a result, the directors consider it appropriate to prepare the financial statements on a going concern basis.

 
2.3

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

 
2.4

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
CRESCENT OPS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)


2.5
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 7 (2021 - 6).

Page 4

 
CRESCENT OPS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

4.


Tangible fixed assets





Equipment

£



Cost or valuation


At 1 January 2022
28,500



At 31 December 2022

28,500



Depreciation


At 1 January 2022
28,500



At 31 December 2022

28,500



Net book value



At 31 December 2022
-



At 31 December 2021
-

Page 5

 
CRESCENT OPS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

5.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2022
930



At 31 December 2022
930






Net book value



At 31 December 2022
930



At 31 December 2021
930


Subsidiary undertaking


The following was a subsidiary undertaking of the Company:

Name

Class of shares

Holding

Crescent Diagnostics (Ireland) Limited
Ordinary
100%


6.


Cash and cash equivalents

2022
2021
£
£

Cash at bank and in hand
1,063
95,123

1,063
95,123



7.


Creditors: Amounts falling due within one year

2022
2021
£
£

Trade creditors
20,604
222,274

Accruals and deferred income
83,146
573,502

103,750
795,776


Page 6

 
CRESCENT OPS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

8.


Creditors: Amounts falling due after more than one year

2022
2021
£
£

Trade creditors
229,000
-

Accruals and deferred income
624,743
-

853,743
-



9.


Share capital

2022
2021
£
£
Allotted, called up and fully paid



333,105 (2021 - 333,110) Ordinary shares of £0.10 each
33,311
33,311



10.


Related party transactions

The company wholly owns its subsidiary, Crescent Diagnostics (Ireland) Limited, a company registered in Ireland, and has taken advantage of the exemption conferred by Financial Reporting Standard 102, section 33, not to disclose transactions with Crescent Diagnostics (Ireland) Limited. 
Included within debtors is £508,826 (2021: £507,193) due from a company which the directors have an interest in.

 
Page 7